September 1, 2007
View Archives Issues
Human papillomavirus (HPV) is the most common sexually transmitted infection in the United States, causing an estimated 6 million new genital infections annually.
Patients with peripheral artery disease are at high risk for cardiovascular complications. Antiplatelet drugs are routinely prescribed for these patients, but is adding an oral anticoagulant of value?